Emergent BioSolutions (EBS) Tops Q3 EPS by 28c
Tweet
Share
E-mailGet Alerts EBS Hot Sheet
Price: $1.90 -2.56%
Revenue Growth %: +12.3%
Financial Fact:
Total revenues: 142.91M
Today's EPS Names:
CPSS, HARL, MCET, More
Revenue Growth %: +12.3%
Financial Fact:
Total revenues: 142.91M
Today's EPS Names:
CPSS, HARL, MCET, More
Join SI Premium – FREE
Emergent BioSolutions (NYSE: EBS) reported Q3 EPS of $0.83, $0.28 better than the analyst estimate of $0.55. Revenue for the quarter came in at $164.9 million versus the consensus estimate of $151.42 million.
Emergent BioSolutions sees FY2015 revenue of $510-540 million.
For earnings history and earnings-related data on Emergent BioSolutions (EBS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Rexford Industrial Realty (REXR) Reports In-Line Q1 EPS, provides guidance
- ASML slides as Q1 sales fall short but firm still on track for 2025 revenue target
- Discover Financial Services (DFS) Reports Q1 EPS of $1.10
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
